tiprankstipranks
Tarsus Pharmaceuticals, Inc. (TARS)
:TARS
US Market

Tarsus Pharmaceuticals (TARS) Income Statement

Compare
218 Followers

Tarsus Pharmaceuticals Income Statement

Last quarter (Q4 2024), Tarsus Pharmaceuticals's total revenue was $66.41M, an increase of 407.86% from the same quarter last year. In Q4, Tarsus Pharmaceuticals's net income was $-23.11M. See Tarsus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 182.95M$ 17.45M$ 25.82M$ 57.03M$ 0.00
Gross Profit
$ 170.13M$ 15.85M$ 24.86M$ 54.95M$ -246.00K
Operating Expenses
$ 290.70M$ 159.01M$ 87.57M$ 67.11M$ 27.00M
Depreciation and Amortization
$ 1.23M$ 877.00K$ 789.00K$ 606.00K$ 246.00K
EBITDA
$ -106.88M$ -131.67M$ -59.11M$ -13.17M$ -26.56M
Operating Income
$ -120.57M$ -143.16M$ -62.71M$ -12.16M$ -27.00M
Other Income/Expenses
$ 5.01M$ 7.26M$ 617.00K$ -1.61M$ 188.00K
Pretax Income
$ -115.55M$ -135.89M$ -62.09M$ -13.77M$ -26.81M
Net Income
$ -115.55M$ -135.89M$ -62.09M$ -13.83M$ -26.81M
Per Share Metrics
Basic EPS
$ -3.07$ -4.62$ -2.52$ -0.67$ -1.32
Diluted EPS
$ -3.07$ -4.62$ -2.52$ -0.67$ -1.32
Weighted Average Shares Outstanding
37.60M 29.38M 24.62M 20.55M 20.32M
Weighted Average Shares Outstanding (Diluted)
37.60M 29.38M 24.62M 20.55M 20.32M
Currency in USD

Tarsus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis